Wenxiang Fan, Xiang Li, Liangliang Huang, Shucheng He, Zhicheng Xie, Yuxin Fu, Weirong Fang, Yunman Li
Index: 10.1016/j.neuint.2018.01.008
Full Text: HTML
Ischemic stroke, the main reason for severe disabilities in the world, is associated with a high incidence of sensorimotor and cognitive dysfunction. In this study, we use the middle cerebral artery occlusion/reperfusion (MCAO/R) model in rats and oxygen glucose deprivation/reoxygenation (OGD/R) model in fetal rat primary cortical neurons to investigate whether and how S-oxiracetam (S-ORC) protect brain injury from ischemic stroke. The results revealed that S-ORC reduced brain infarct size and lessened neurological dysfunction after stroke. Further study demonstrated that S-ORC diminished TUNEL positive cells, increased cell viability, decreased LDH activity, and inhibited cell apoptotic rate. Furthermore, S-ORC inhibited neuronal apoptosis by activating the PI3K/Akt/GSK3β signaling pathway via α7 nAChR, which was evidenced by α7 nAChR siRNA. In conclusion, our findings strongly suggest that S-ORC could be used as an effective neuroprotective agent for ischemic stroke due to its effect in preventing neuronal apoptosis.
|
Repeated peripheral administration of lipidized prolactin-re...
2018-03-27 [10.1016/j.neuint.2018.03.013] |
|
Current perspective of mitochondrial biology in Parkinson's ...
2018-03-14 [10.1016/j.neuint.2018.03.001] |
|
Deletion of serine racemase confers D-serine –dependent resi...
2018-03-14 [10.1016/j.neuint.2018.03.008] |
|
X-ray irradiation induces disruption of the blood–brain barr...
2018-03-12 [10.1016/j.neuint.2018.03.002] |
|
Neuromuscular synapse degeneration without muscle function l...
2018-03-10 [10.1016/j.neuint.2018.03.007] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved